Hitaxa Fast Junior (Desloratadine)

Hitaxa Fast Junior is indicated for the relief of allergic symptoms in children. It is commonly prescribed for conditions where histamine release contributes to discomfort.

• Seasonal allergic rhinitis (hay fever) in pediatric patients
• Perennial allergic rhinitis caused by indoor allergens
• Chronic idiopathic urticaria (hives) with frequent flare‑ups
• Relief of sneezing, nasal congestion, itching, and watery eyes associated with allergic rhinitis
• Management of itching and rash in children with urticaria

• Desloratadine, the active ingredient in Hitaxa Fast Junior, selectively blocks peripheral H1 histamine receptors. By preventing histamine from binding to these receptors, it reduces the vascular permeability, nerve stimulation, and glandular secretion that underlie typical allergic responses. The drug does not readily cross the blood‑brain barrier, which limits central nervous system effects and contributes to its non‑sedating profile.

Side effects of Hitaxa Fast Junior are generally mild, but some reactions may require medical attention.

Common

• Headache
• Dry mouth
• Fatigue or mild drowsiness
• Nausea or abdominal discomfort
• Mild skin rash

Serious

• Severe allergic reaction (anaphylaxis) with swelling, difficulty breathing, or hives
• Cardiac arrhythmia in susceptible individuals
• Significant liver enzyme elevation
• Persistent or worsening urticaria despite therapy

Before using Hitaxa Fast Junior, consider the following safety points:

• Verify the child’s age and weight to ensure appropriate use.
• Consult a healthcare professional if the child has liver or kidney impairment.
• Use caution in patients with a history of heart rhythm disorders.
• Avoid use during pregnancy or breastfeeding unless advised by a physician.
• Monitor for signs of an allergic reaction, especially during the first few doses.
• Keep the medication out of reach of children to prevent accidental overdose.

Hitaxa Fast Junior may interact with other medicines; consider these guidelines:

Avoid

• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) that can increase desloratadine levels.
• Monoamine oxidase inhibitors (MAOIs) taken within 14 days of the antihistamine.

Use with caution

• Alcohol, which may enhance sedation in sensitive individuals.
• Other antihistamines or sedating medications, potentially increasing drowsiness.
• Antifungal agents that affect hepatic metabolism.
• Certain antidepressants (e.g., fluoxetine) that share metabolic pathways.
• Over‑the‑counter cough or cold preparations containing antihistamines.